title: Tracking of green fluorescent protein (GFP)-labeled LAK cells in mice carrying B16 melanoma metastases.
abstract: In adoptive immunotherapy, in vivo trafficking of adoptively transferred cells, including their accumulation at tumor sites, remains to be further investigated. Tracking of these cells by visualization is useful to clarify antitumor mechanisms and develop new modalities to enhance antitumor capacities. In the present study, an in vivo tracking study was performed using an adoptive transfer model of lymphokine-activated killer (LAK) cells induced from green mice into C57/BL6 mice with B16 melanoma metastases. Green mice are green fluorescent protein (GFP) transgenic mice originating from C57/BL6 mice. All of the tissues, except for erythrocytes and hair, express green fluorescence under excitation light. Although LAK cells in combination with IL-2 potently suppressed pulmonary metastases with survival prolongation, very few LAK cells accumulated in tumor tissues compared to those localized in the spleen, as visualized by fluorescent microscopy and quantitated by flow cytometry. The present method using transfer of green mice-derived cells into parental tumor-bearing mice is simple because there is no need for in vitro labeling and is feasible for the in vivo tracking of effector cells in an adoptive immunotherapy model.
authors.affiliation: Department of Surgery, Division of Digestive Surgery, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto 602-0841, Japan.
authors.forename: Kazuhiro
authors.initials: K
authors.lastname: Takashima
authors.forename: Hitoshi
authors.initials: H
authors.lastname: Fujiwara
authors.forename: Satoshi
authors.initials: S
authors.lastname: Inada
authors.forename: Kiyoto
authors.initials: K
authors.lastname: Atsuji
authors.forename: Yasunobu
authors.initials: Y
authors.lastname: Araki
authors.forename: Takeshi
authors.initials: T
authors.lastname: Kubota
authors.forename: Hisakazu
authors.initials: H
authors.lastname: Yamagishi
mesh_terms: D000818:Animals; D005434:Flow Cytometry; D049452:Green Fluorescent Proteins / Q000493:pharmacokinetics*; D007376:Interleukin-2 / Q000627:therapeutic use; D015979:Killer Cells, Lymphokine-Activated / Q000378:metabolism / Q000473:pathology* / Q000637:transplantation; D008175:Lung Neoplasms / Q000188:drug therapy / Q000378:metabolism* / Q000556:secondary; D008546:Melanoma, Experimental / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology*; D051379:Mice; D008810:Mice, Inbred C57BL; D008856:Microscopy, Fluorescence; D013154:Spleen / Q000378:metabolism / Q000473:pathology; D015996:Survival Rate
chemical_list: D007376:Interleukin-2; D049452:Green Fluorescent Proteins